Impaired functions of neural stem cells by abnormal nitric oxide-mediated signaling in an in vitro model of Niemann-Pick type C disease

Cell Research

Volumn 18, Issue 6, 2008, Pages 686-694

  Kim, Sun Jung ^a   Lim, Myung Sin ^a   Kang, Soo Kyung ^b   Lee, Yong Soon ^a   Kang, Kyung Sun ^a  

^a Seoul National University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Caspase 3; GSK3 ; Neural stem cells; Niemann Pick type C1 disease; Nitric oxide

Indexed keywords

CASPASE 3; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; INTERMEDIATE FILAMENT PROTEIN; N(G) NITROARGININE METHYL ESTER; NERVE PROTEIN; NESTIN; NITRIC OXIDE; NPC1 PROTEIN, MOUSE; PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODEL; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; HOMOZYGOTE; METABOLISM; MOUSE; NERVE CELL; NERVE DEGENERATION; NIEMANN PICK DISEASE; PATHOLOGY; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; CASPASE 3; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; HOMOZYGOTE; INTERMEDIATE FILAMENT PROTEINS; MICE; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEURONS; NG-NITROARGININE METHYL ESTER; NIEMANN-PICK DISEASES; NITRIC OXIDE; PROTEINS; SIGNAL TRANSDUCTION; STEM CELLS;

ANIMALIA; MUS;

EID: 44849141340     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2008.48     Document Type: Article

References (48)

1. Gage FH. Mammalian neural stem cells. Science 2000; 287:1433-1438.
2. Kleber M, Lee HY, Wurdak H, et al. Neural crest stem cell maintenance by combinatorial Wnt and BMP signaling. J Cell Biol 2005; 169:309-320.
3. Tokunaga A, Kohyama J, Yoshida T, et al. Mapping spatio-temporal activation of Notch signaling during neurogenesis and gliogenesis in the developing mouse brain. J Neurochem 2004; 90:142-154.
4. Torroglosa A, Murillo-Carretero M, Romero-Grimaldi C, et al. Nitric oxide decreases subventricular zone stem cell proliferation by inhibition of epidermal growth factor receptor and phosphoinosit-ide-3-kinase/Akt pathway. Stem Cells 2007; 25:88-97.
5. Covacu R, Danilov AI, Rasmussen BS, et al. Nitric oxide exposure diverts neural stem cell fate from neurogenesis towards astrogliogenesis. Stem Cells 2006; 24:2792-2800.
6. Sehara Y, Hayashi T, Deguchi K, et al. Distribution of inducible nitric oxide synthase and cell proliferation in rat brain after transient middle cerebral artery occlusion. Brain Res 2006; 1093:190-197.
7. Estrada C, Murillo-Carretero M. Nitric oxide and adult neurogenesis in health and disease. Neuroscientist 2005; 11:294-307.
8. Chung KK, Dawson VL, Dawson TM. S-nitrosylation in Parkinson's disease and related neurodegenerative disorders. Methods Enzymol 2005; 396:139-150.
9. Suzuki K, Parker CC, Pentchev PG, et al. Neurofbrillary tangles in Niemann-Pick disease type C. Acta Neuropathol (Berl) 1995; 89:227-238.
10. Love S, Bridges LR, Case CP. Neurofbrillary tangles in Niemann-Pick disease type C. Brain 1995; 118(Pt 1):119-129.
11. Yu W, Gong JS, Ko M, et al. Altered cholesterol metabolism in Niemann-Pick type C1 mouse brains affects mitochondrial function. J Biol Chem 2005; 280:11731-11739.
12. Yang SR, Kim SJ, Byun KH, et al. NPC1 gene defciency leads to lack of neural stem cell self-renewal and abnormal differentiation through activation of p38 mitogen-activated protein kinase signaling. Stem Cells 2006; 24:292-298.
13. Malinski T. Nitric oxide and nitroxidative stress in Alzheimer's disease. J Alzheimer's Dis 2007; 11:207-218.
14. Moncada S, Bolanos JP. Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 2006; 97:1676-1689.
15. Heneka MT, Wiesinger H, Dumitrescu-Ozimek L, et al. Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease. J Neuropathol Exp Neurol 2001; 60:906-916.
16. Guthrie SM, Curtis LM, Mames RN, et al. The nitric oxide pathway modulates hemangioblast activity of adult hematopoietic stem cells. Blood 2005; 105:1916-1922.
17. Ellis EA, Sengupta N, Caballero S, et al. Nitric oxide synthases modulate progenitor and resident endothelial cell behavior in galactosemia. Antioxid Redox Signal 2005; 7:1413-1422.
18. Castillo SS, Levy M, Wang C, et al. Nitric oxide-enhanced caspase-3 and acidic sphingomyelinase interaction: a novel mechanism by which airway epithelial cells escape ceramide-induced apoptosis. Exp Cell Res 2007; 313:816-823.
19. Lu J, Moochhala S, Shirhan M, et al. Nitric oxide induces macrophage apoptosis following traumatic brain injury in rats. Neurosci Lett 2003; 339:147-150.
20. Cassina P, Peluffo H, Pehar M, et al. Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis. J Neurosci Res 2002; 67:21-29.
21. Zhang YJ, Xu YF, Liu YH, Yin J, Wang JZ. Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3â activation. FEBS Lett 2005; 579:6230-6236.
22. Beurel E, Jope RS. The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog Neurobiol 2006; 79:173-189.
23. Ghatan S, Larner S, Kinoshita Y, et al. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J Cell Biol 2000; 150:335-347.
24. Auer IA, Schmidt ML, Lee VM, et al. Paired helical flament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease. Acta Neuropathol (Berl) 1995; 90:547-551.
25. Ohm TG, Treiber-Held S, Distl R, et al. Cholesterol and tau protein - fndings in Alzheimer's and Niemann Pick C's disease. Pharmacopsychiatry 2003; 36(Suppl 2):S120-S126.
26. Molofsky AV, Pardal R, Morrison SJ. Diverse mechanisms regulate stem cell self-renewal. Curr Opin Cell Biol 2004; 16:700-707.
27. Molofsky AV, Pardal R, Iwashita T, et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003; 425:962-967.
28. Groszer M, Erickson R, Scripture-Adams DD, et al. PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry. Proc Natl Acad Sci USA 2006; 103:111-116.
29. Packer MA, Stasiv Y, Benraiss A, et al. Nitric oxide negatively regulates mammalian adult neurogenesis. Proc Natl Acad Sci USA 2003; 100:9566-9571.
30. Cheng A, Chan SL, Milhavet O, Wang S, Mattson MP. p38 MAP kinase mediates nitric oxide-induced apoptosis of neural progenitor cells. J Biol Chem 2001; 276:43320-43327.
31. Millard EE, Gale SE, Dudley N, et al. The sterol-sensing domain of the Niemann-Pick C1 (NPC1) protein regulates traffck-ing of low density lipoprotein cholesterol. J Biol Chem 2005; 280:28581-28590.
32. Danik M, Champagne D, Petit-Turcotte C, Beffert U, Poirier J. Brain lipoprotein metabolism and its relation to neurodegenerative disease. Crit Rev Neurobiol 1999; 13:357-407.
33. Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci USA 2006; 103:5644-5651.
34. Nanetti L, Vignini A, Moroni C, Pessina GP, Mazzanti L. LDL and HDL affect nitric oxide metabolism in human astrocytoma cells. Brain Res 2004; 1020:173-177.
35. Nanetti L, Vignini A, Moroni C, et al. Peroxynitrite production and NOS expression in astrocytes U373MG incubated with lipoproteins from Alzheimer patients. Brain Res 2005; 1054:38-44.
36. Katsuki H, Okawara M, Shibata H, Kume T, Akaike A. Nitric oxide-producing microglia mediate thrombin-induced degeneration of dopaminergic neurons in rat midbrain slice culture. J Neurochem 2006; 97:1232-1242.
37. Castegna A, Thongboonkerd V, Klein JB, et al. Proteomic identifcation of nitrated proteins in Alzheimer's disease brain. J Neurochem 2003; 85:1394-1401.
38. Noble W, Planel E, Zehr C, et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci USA 2005; 102:6990-6995.
39. Trowbridge JJ, Xenocostas A, Moon RT, Bhatia M. Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation. Nat Med 2006; 12:89-98.
40. Israsena N, Hu M, Fu W, Kan L, Kessler JA. The presence of FGF2 signaling determines whether ß-catenin exerts effects on proliferation or neuronal differentiation of neural stem cells. Dev Biol 2004; 268:220-231.
41. Mani K, Cheng F, Fransson LA. Defective nitric oxide-dependent, deaminative cleavage of glypican-1 heparan sulfate in Niemann-Pick C1 fbroblasts. Glycobiology 2006; 16:711-718.
42. Vance JE. Lipid imbalance in the neurological disorder, Niemann-Pick C disease. FEBS Lett 2006; 580:5518-5524.
43. Vanier MT, Millat G. Niemann-Pick disease type C. Clin Genet 2003; 64:269-281.
44. Nixon RA. Niemann-Pick Type C disease and Alzheimer's disease: the APP-endosome connection fattens up. Am J Pathol 2004; 164:757-761.
45. Erickson RP, Garver WS, Camargo F, Hossain GS, Heidenreich RA. Pharmacological and genetic modifcations of somatic cholesterol do not substantially alter the course of CNS disease in Niemann-Pick C mice. J Inherit Metab Dis 2000; 23:54-62.
46. Fink JK, Filling-Katz MR, Sokol J, et al. Clinical spectrum of Niemann-Pick disease type C. Neurology 1989; 39:1040-1049.
47. Griffn LD, Gong W, Verot L, Mellon SH. Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat Med 2004; 10:704-711.
48. Schmued LC, Stowers CC, Scallet AC, Xu L. Fluoro-ade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res 2005; 1035:24-31.